News
The REAL8 basket study showed Sogroya (somapacitan) was non-inferior to Norditropin (somatropin) in improving yearly growth ...
Final overall survival results from the Phase III APHINITY trial show a 17% reduction in the risk of death at 10 years for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback